Hopp til hovedinnhold

Tardive syndromer

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. Mulroy E, Balint B, Bhatia KP. Tardive syndromes. Pract Neurol. 2020 Oct;20(5):368-376. PMID: 32487722. PubMed  
  2. Fernandez HH, Factor SA, Hauser RA, Jimenez-Shahed J, Ondo WG, Jarskog LF, Meltzer HY, Woods SW, Bega D, LeDoux MS, Shprecher DR, Davis C, Davis MD, Stamler D, Anderson KE. Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD stud. Neurology 2017. pmid:28446646 PubMed  
  3. Fernandez HH, Stamler D, Davis MD, Factor SA, Hauser RA, Jimenez-Shahed J, Ondo WG, Jarskog LF, Woods SW, Bega D, LeDoux MS, Shprecher DR, Anderson KE. Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia. J Neurol Neurosurg Psychiatry 2019. pmid:31296586 PubMed  
  4. Anderson KE, Stamler D, Davis MD, Factor SA, Hauser RA, Isojärvi J, Jarskog LF, Jimenez-Shahed J, Kumar R, McEvoy JP, Ochudlo S, Ondo WG, Fernandez HH.. Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Psychiatry 2017. pmid:28668671 PubMed  
  5. Hauser RA, Barkay H, Fernandez HH, Factor SA, Jimenez-Shahed J, Gross N, Marinelli L, Wilhelm A, Gordon MF, Savola JM, Anderson KE. Long-Term Deutetrabenazine Treatment Is Associated With Continued Improvement in Tardive Dyskinesia in the Completed 3-Year Open-Label Extension Study. CNS Spectr. 2021 Apr;26(2):162. PMID: 34127136. PubMed  
  6. Bhidayasiri R, Fahn S, Weiner WJ, Gronseth GS, Sullivan KL, Zesiewicz TA; American Academy of Neurology. Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013 Jul 30;81(5):463-9 . pmid:23897874 PubMed  
  7. Krause P, Kroneberg D, Gruber D, Koch K, Schneider GH, Kühn AA. Long-term effects of pallidal deep brain stimulation in tardive dystonia: a follow-up of 5-14 years. J Neurol. 2022 Jul;269(7):3563-3568. doi: 10.1007/s00415-022-10965-8. Epub 2022 Jan 27. PMID: 35083518 PubMed  
  8. Morigaki R, Mure H, Kaji R, Nagahiro S, Goto S. Therapeutic Perspective on Tardive Syndrome with Special Reference to Deep Brain Stimulation. Front Psychiatry. 2016 Dec 26;7:207. pmid:28082923 PubMed  
  9. Waln O, Jankovic J. Zolpidem improves tardive dyskinesia and akathisia. Mov Disord. 2013 Oct;28(12):1748-9 . pmid:23637028 PubMed  
  10. Santoro MA, English I, Sezer I, Amagat M, Ly F, Chaneac E, Cailliez P, Bottemanne H. Improvement of Tardive Dyskinesia during Mindfulness Meditation. Neurol Int. 2021 Aug 30;13(3):439-444. PMID: 34564288 PubMed  
  • Åse Mygland, spesialist i nevrologi, professor dr med
  • Unn Ljøstad, spesialist i nevrologi, professor PhD